• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色氨酸代谢产物吲哚-3-乙酸在袖状胃切除术后非酒精性脂肪性肝病改善中的作用

Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy.

机构信息

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

出版信息

Obes Surg. 2021 Jul;31(7):3040-3052. doi: 10.1007/s11695-021-05321-0. Epub 2021 May 10.

DOI:10.1007/s11695-021-05321-0
PMID:33973136
Abstract

BACKGROUND

This study aimed to investigate the weight-independent mechanism of sleeve gastrectomy on the relief of nonalcoholic fatty liver disease (NAFLD).

METHODS

A total of 58 obese patients who had undergone sleeve gastrostomy (SG) were recruited. Plasma levels of indole-3-acetic acid (I3A), a metabolite from gut microbiota before and after SG were investigated. In addition, we had 78 C57BL/6J mice included in the study. High-fat diet (HFD) was used to induce obesity in mice. Sleeve gastrectomy (SG) was then performed. The liver of the mice was analyzed by HE and oil red staining to study lipid accumulation. Fluorescence-activated cell sorting (FACS) analysis was performed to study the phenotype of macrophages in the liver. The levels of I3A in serum, stool, and liver were tested by ELISA. Macrophages and hepatocytes were cultured in vitro and stimulated with I3A to study the effects on differentiation and proliferation/apoptosis.

RESULTS

In human samples, I3A increased after SG and plasma I3A levels were positively correlated with liver CT values and negatively correlated with liver fat attenuation. In mice models, after surgery, the percentage of M2 macrophages significantly increased in the liver. Both oral gavage and in vitro stimulation of I3A could promote M2 differentiation and did not significantly affect the state of hepatocytes.

CONCLUSIONS

This study suggested that increased I3A from the intestine after SG could reduce the M1/M2 ratio in the liver and thus promote relief of NAFLD in obese individuals. Graphical Abstract.

摘要

背景

本研究旨在探讨袖状胃切除术减轻非酒精性脂肪性肝病(NAFLD)的体重独立机制。

方法

共招募了 58 例接受袖状胃切除术(SG)的肥胖患者。研究了 SG 前后肠道微生物群的吲哚-3-乙酸(I3A)代谢物在血浆中的水平。此外,我们还纳入了 78 只 C57BL/6J 小鼠。使用高脂肪饮食(HFD)诱导小鼠肥胖,然后进行袖状胃切除术(SG)。通过 HE 和油红染色分析小鼠肝脏,研究脂质积累。采用荧光激活细胞分选(FACS)分析研究肝脏中巨噬细胞的表型。通过 ELISA 检测血清、粪便和肝脏中的 I3A 水平。体外培养巨噬细胞和肝细胞,用 I3A 刺激,研究其对分化和增殖/凋亡的影响。

结果

在人体样本中,SG 后 I3A 增加,血浆 I3A 水平与肝脏 CT 值呈正相关,与肝脏脂肪衰减呈负相关。在小鼠模型中,手术后肝脏中 M2 巨噬细胞的比例明显增加。口服灌胃和体外刺激 I3A 均可促进 M2 分化,且对肝细胞状态无明显影响。

结论

本研究表明,SG 后肠道中 I3A 的增加可以降低肝脏中 M1/M2 比值,从而促进肥胖个体中 NAFLD 的缓解。图表摘要。

相似文献

1
Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy.色氨酸代谢产物吲哚-3-乙酸在袖状胃切除术后非酒精性脂肪性肝病改善中的作用
Obes Surg. 2021 Jul;31(7):3040-3052. doi: 10.1007/s11695-021-05321-0. Epub 2021 May 10.
2
Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice.袖状胃切除术改善了高脂肪饮食(HFD)诱导的非酒精性脂肪肝疾病,并在小鼠中上调了烟酰胺腺嘌呤二核苷酸+/Sirtuin-1 通路。
Asian J Surg. 2021 Jan;44(1):213-220. doi: 10.1016/j.asjsur.2020.05.030. Epub 2020 Jul 22.
3
Increase in bile acids after sleeve gastrectomy improves metabolism by activating GPBAR1 to increase cAMP in mice with nonalcoholic fatty liver disease.袖状胃切除术后胆汁酸增加通过激活 GPBAR1 以增加非酒精性脂肪性肝病小鼠中的 cAMP 改善代谢。
Immun Inflamm Dis. 2024 Jul;12(7):e1149. doi: 10.1002/iid3.1149.
4
Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy.Setdb2 的下调通过 PI3K/Akt 通路促进巨噬细胞的替代激活,从而减轻袖状胃切除术后非酒精性脂肪性肝病。
Biochem Biophys Res Commun. 2024 Sep 24;726:150264. doi: 10.1016/j.bbrc.2024.150264. Epub 2024 Jun 13.
5
Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease.袖状胃切除术可减轻高脂饮食诱导的非酒精性脂肪肝。
Lipids Health Dis. 2018 Oct 24;17(1):243. doi: 10.1186/s12944-018-0875-5.
6
Changes in Hepatic Fat Content by CT 1 Year After Sleeve Gastrectomy in Adolescents and Young Adults With Obesity.肥胖青少年和年轻成人行袖状胃切除术后 1 年肝脏脂肪含量的 CT 变化。
J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1489-e1495. doi: 10.1210/clinem/dgad390.
7
Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity.减重手术后血浆染料木黄酮水平升高可能促进肥胖患者非酒精性脂肪性肝病的缓解。
Front Endocrinol (Lausanne). 2023 Jan 4;13:1024769. doi: 10.3389/fendo.2022.1024769. eCollection 2022.
8
MiR-200c-3p Regulates DUSP1/MAPK Pathway in the Nonalcoholic Fatty Liver After Laparoscopic Sleeve Gastrectomy.腹腔镜袖状胃切除术后非酒精性脂肪肝中 miR-200c-3p 调控 DUSP1/MAPK 通路。
Front Endocrinol (Lausanne). 2022 Mar 1;13:792439. doi: 10.3389/fendo.2022.792439. eCollection 2022.
9
Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病动物模型中袖状胃切除术后及极低热量饮食后的形态功能变化
Obes Surg. 2018 Jan;28(1):142-151. doi: 10.1007/s11695-017-2805-4.
10
Amelioration of NAFLD by sleeve gastrectomy-triggered hepatocyte regeneration in mice - experimental research.袖状胃切除术触发肝细胞再生改善非酒精性脂肪性肝病的实验研究。
Int J Surg. 2024 Jun 1;110(6):3307-3325. doi: 10.1097/JS9.0000000000001387.

引用本文的文献

1
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics.非酒精性脂肪性肝病中的肠道微生物群:病理生理学、诊断与治疗
World J Hepatol. 2025 Jun 27;17(6):106849. doi: 10.4254/wjh.v17.i6.106849.
2
The Obesity-Epigenetics-Microbiome Axis: Strategies for Therapeutic Intervention.肥胖-表观遗传学-微生物群轴:治疗干预策略
Nutrients. 2025 May 1;17(9):1564. doi: 10.3390/nu17091564.
3
Fecal transplantation from humans with obesity to mice drives a selective microbial signature without impacting behavioral and metabolic health.

本文引用的文献

1
Vertical sleeve gastrectomy induces distinctive transcriptomic responses in liver, fat and muscle.垂直袖状胃切除术可诱导肝脏、脂肪和肌肉中独特的转录组反应。
Sci Rep. 2021 Jan 27;11(1):2310. doi: 10.1038/s41598-021-81866-5.
2
FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation.成纤维细胞生长因子21调节肝脏代谢途径以改善脂肪变性和炎症。
Endocr Connect. 2020 Aug;9(8):755-768. doi: 10.1530/EC-20-0152.
3
Interventions for the management of obesity in people with bipolar disorder.双相情感障碍患者肥胖管理的干预措施。
将肥胖人群的粪便移植到小鼠体内会产生一种选择性的微生物特征,而不会影响行为和代谢健康。
Sci Rep. 2025 May 2;15(1):15455. doi: 10.1038/s41598-025-99047-z.
4
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics.肠道微生物群与宿主化学通讯的表型分析:次级胆汁酸作为益生元后体。
Cells. 2025 Apr 15;14(8):595. doi: 10.3390/cells14080595.
5
Postbiotics as Antiinflammatory and Immune-Modulating Bioactive Compounds in Metabolic Dysfunction-Associated Steatotic Liver Disease.后生元作为代谢功能障碍相关脂肪性肝病中的抗炎和免疫调节生物活性化合物
Mol Nutr Food Res. 2024 Dec;68(23):e2400754. doi: 10.1002/mnfr.202400754. Epub 2024 Nov 5.
6
The effect of intestinal flora metabolites on macrophage polarization.肠道菌群代谢产物对巨噬细胞极化的影响。
Heliyon. 2024 Aug 3;10(15):e35755. doi: 10.1016/j.heliyon.2024.e35755. eCollection 2024 Aug 15.
7
Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches.利用先进的制药方法将微生物代谢物作为治疗药物进行传递。
Pharmacol Ther. 2024 Apr;256:108605. doi: 10.1016/j.pharmthera.2024.108605. Epub 2024 Feb 16.
8
Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的肠道微生物与肝巨噬细胞极化
Front Microbiol. 2023 Dec 6;14:1285473. doi: 10.3389/fmicb.2023.1285473. eCollection 2023.
9
Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease.目前对肠道微生物群衍生代谢产物与代谢相关脂肪性肝病之间相互作用的见解。
Tzu Chi Med J. 2023 Sep 7;35(4):290-299. doi: 10.4103/tcmj.tcmj_122_23. eCollection 2023 Oct-Dec.
10
Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment.肠道微生物群与肿瘤相关巨噬细胞:在肿瘤诊断和治疗中的潜力。
Gut Microbes. 2023 Dec;15(2):2276314. doi: 10.1080/19490976.2023.2276314. Epub 2023 Nov 9.
Cochrane Database Syst Rev. 2020 Jul 20;7(7):CD013006. doi: 10.1002/14651858.CD013006.pub2.
4
Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎中肝脏巨噬细胞与周围细胞的串扰。
Front Immunol. 2020 Jun 24;11:1169. doi: 10.3389/fimmu.2020.01169. eCollection 2020.
5
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.代谢性炎症在非酒精性脂肪性肝病中作为肝纤维化的启动因素。
World J Gastroenterol. 2020 May 7;26(17):1993-2011. doi: 10.3748/wjg.v26.i17.1993.
6
Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis: A Retrospective Cohort Analysis.减重手术与非酒精性脂肪性肝病向肝硬化的进展减少相关:一项回顾性队列分析。
Ann Surg. 2020 Jul;272(1):32-39. doi: 10.1097/SLA.0000000000003871.
7
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages.肠道微生物群衍生的色氨酸代谢产物调节肝细胞和巨噬细胞中的炎症反应。
Cell Rep. 2019 Sep 17;28(12):3285. doi: 10.1016/j.celrep.2019.08.080.
8
Outside the liver box: The gut microbiota as pivotal modulator of liver diseases.肝外之“盒”:肠道微生物群作为肝脏疾病关键调节者。
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):912-919. doi: 10.1016/j.bbadis.2018.07.004. Epub 2018 Jul 6.
9
Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE mice.阿魏酸可改善高脂饮食喂养的载脂蛋白 E 基因敲除小鼠的非酒精性脂肪性肝病,并调节其肠道微生物组成。
Biomed Pharmacother. 2019 May;113:108753. doi: 10.1016/j.biopha.2019.108753. Epub 2019 Mar 9.
10
Macrophages: versatile players in renal inflammation and fibrosis.巨噬细胞:肾脏炎症和纤维化中的多面手。
Nat Rev Nephrol. 2019 Mar;15(3):144-158. doi: 10.1038/s41581-019-0110-2. Epub 2019 Jan 28.